wegovy.com

DR 74by Ahrefs中等机会 · 60/100

产品简介

Wegovy® (semaglutide) injection 2.4 mg or tablets 25 mg aids in adults with obesity or some with overweight with weight related conditions. Read Important Safety and Prescribing Info, including Boxed Warning.

类别health/pharmacy

前 51,098 名

全球排名

United States 81%

主要市场

-8%

月度趋势

56% 跳出率

参与度信号

月访问量

1,284,507

↓7.8% vs last month

跳出率

56.1%

每访页面数

1.9

平均时长

1m 4s

域名年龄

5.7 years

流量分析

#51,098全球排名

#11,324国家排名 (840)

#13分类排名 · Pharmacy

流量趋势

↓7.8%

流量来源

Organic Search

55.9%

Direct

15.6%

Social

6.7%

Referral

2.3%

Paid

16.7%

2.8%

Active ad spend: 16.7% from paid traffic

Geographic Distribution

域名占比

🇺🇸United StatesUS

81.3%

🇬🇧United KingdomGB

1.9%

🇮🇳IndiaIN

1.7%

Top 3 countries account for 84.9% of traffic — high geographic concentration

SEO 与关键词

热门关键词

关键词
wegovy	282.0K	$8.58	$49.2K
semaglutide	127.7K	$11.93	$3.8K
wegovy pill	55.6K	$18.98	$20.6K
wegovy coupon	8.3K	$9.05	$7.8K
wegovy savings card	8.0K	$10.12	$4.2K

SERP 排名

关键词			排名 URL
semaglutide	#5	🏠	www.wegovy.com/	127,950	$10.95

增长速读

流量连续 3 个月下滑，近期表现承压

付费流量占比 17%——正在投广告

流量集中在United States（81%）——地理依赖度高

wegovy.com 到底是怎么增长的？

这个页面只是概览。增长拆解报告会逆向工程它的完整增长路径——哪些关键词带来注册、外链从哪里来、哪个渠道真正转化、以及你可以直接复制的策略。

竞品格局

TrimRx

trimrx.com

🔗 2 个重叠词

TrimRx is an online telehealth company that specializes in personalized weight loss programs using GLP-1 medications like Semaglutide and Tirzepatide. Connecting users with licensed medical providers, FDA-registered pharmacies, and a focus on safety, effectiveness, and ongoing support, TrimRx has helped thousands of clients across the U.S. achieve their weight loss goals.

5.0M/mo+24%2019年7月$249.2K MRR

共享 2 个关键词，包括"wegovy"

wegovy.com vs TrimRx →访问网站 ↗

novomedlink.com

🔗 2 个重叠词

Browse the Rivfloza® product resources library for health care professionals, including prescribing information, mechanism of action, and more.

161.2K/mo-16%2003年3月

共享 2 个关键词，包括"wegovy"

wegovy.com vs novomedlink.com →访问网站 ↗

查看 wegovy.com 的完整竞品分析 →

报告数据基于网站 2026年5月的数据生成

查看样例报告